Nevertheless, the FDA recently approved a dopamine transporter (DAT) single-photon emission computerized tomography (SPECT) to evaluate suspicions of Parkinson’s disease, which can be seen as evidence of the next imaging-based diagnostic in AD [46]. The gene discussed is SLC6A3; the disease is Parkinson disease.